Okuno Masayuki 奥野将之

Researcher Number	10844011
Other IDs
Affiliation (Current)	2025: 京都大学, 医学研究科, 特定病院助教
Affiliation (based on the past Project Information) *help	2023: 兵庫医科大学, 医学部, 非常勤講師 2020 – 2022: 兵庫医科大学, 医学部, 助教 2019: 京都大学, 医学研究科, 客員研究員
Review Section/Research Field	Principal Investigator Basic Section 55020:Digestive surgery-related / 0905:Surgery of the organs maintaining homeostasis and related fields
Keywords	Principal Investigator 血管新生 / 肝細胞癌 / 免疫療法 / 転移性大腸癌 / 癌微小環境 / 微小環境 / 腫瘍免疫 / 循環腫瘍細胞

Impact of vessel co-option on systemic chemotherapy for hepatocellular carcinomaPrincipal Investigator
- Principal Investigator
  
  奥野将之
- Project Period (FY)
  2021 – 2024
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 55020:Digestive surgery-related
- Research Institution
  Hyogo Medical University
Exploration of target molecule for immunotherapy focusing on natural immuno-system of circulating tumor cellPrincipal Investigator
- Principal Investigator
  
  Okuno Masayuki
- Project Period (FY)
  2019 – 2022
- Research Category
  
  Grant-in-Aid for Research Activity Start-up
- Review Section
  
  0905:Surgery of the organs maintaining homeostasis and related fields
- Research Institution
  Hyogo Medical University
  Kyoto University

All 2024 2023 2021

All Journal Article Presentation

[Journal Article] Surgical Intervention After Lenvatinib Treatment in Patients With Advanced Hepatocellular Carcinoma2024
- Author(s)
  OKUNO MASAYUKI、HATANO ETSURO、TADA MASAHARU、NISHIMURA TAKASHI、OKAMOTO TOMOHIRO、SUEOKA HIDEAKI、IIDA KENJIRO、NAKAMURA IKUO、IIJIMA HIROKO、HIRONO SEIKO
- Journal Title
  
  Anticancer Research
  
  Volume: 44 Issue: 4 Pages: 1727-1737
- DOI
  10.21873/anticanres.16972
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K16486, KAKENHI-PROJECT-21K08803
[Journal Article] A patient who underwent conversion surgery after atezolizumab plus bevacizumab for hepatocellular carcinoma with portal vein thrombosis and perihepatic lymph node metastases achieved a pathological complete response2024
- Author(s)
  Okuno Masayuki、Ohama Hideko、Nakamura Ikuo、Yoshida Makoto、Shirai Daisuke、Hirai Takahito、Fuji Hiroaki、Kurimoto Ami、Okamoto Tomohiro、Sueoka Hideaki、Iida Kenjiro、Tada Masaharu、Kihara Takako、Tanaka Hironori、Hirono Seiko
- Journal Title
  
  International Cancer Conference Journal
  
  Volume: - Issue: 3 Pages: 306-312
- DOI
  10.1007/s13691-024-00683-5
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K16486
[Journal Article] Sinusoidal Obstruction Syndrome Promotes Liver Metastatic Seeding of Colorectal Cancer Cells in a Rat Model. Anticancer Res. 2021;41(4):1803-1810. doi: 10.21873/anticanres.14946.2021
- Author(s)
  Nishino H, Okuno M, Seo S, Toda R, Yoshino K, Kasai Y, Satoh M, Iwaisako K, Taura K, Hatano E.
- Journal Title
  
  Anticancer Res.
  
  Volume: 41(4) Issue: 4 Pages: 1803-1810
- DOI
  10.21873/anticanres.14946
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K08996, KAKENHI-PROJECT-20K09006, KAKENHI-PROJECT-19K24009
[Presentation] Surgical intervention after lenvatinib treatment in patients with advanced hepatocellular carcinoma2023
- Author(s)
  Masayuki Okuno
- Organizer
  Kansai- Yeungnam HBP Surgeons Meeting 2023
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K16486

1. 祝迫惠子

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
2. 瀬尾智

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Okuno Masayuki 奥野将之

Research Projects

Research Products

Co-Researchers

Impact of vessel co-option on systemic chemotherapy for hepatocellular carcinomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Exploration of target molecule for immunotherapy focusing on natural immuno-system of circulating tumor cellPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Surgical Intervention After Lenvatinib Treatment in Patients With Advanced Hepatocellular Carcinoma2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] A patient who underwent conversion surgery after atezolizumab plus bevacizumab for hepatocellular carcinoma with portal vein thrombosis and perihepatic lymph node metastases achieved a pathological complete response2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Sinusoidal Obstruction Syndrome Promotes Liver Metastatic Seeding of Colorectal Cancer Cells in a Rat Model. Anticancer Res. 2021;41(4):1803-1810. doi: 10.21873/anticanres.14946.2021

Author(s)

Journal Title

DOI

Data Source

[Presentation] Surgical intervention after lenvatinib treatment in patients with advanced hepatocellular carcinoma2023

Author(s)

Organizer

Data Source

Okuno Masayuki 奥野 将之

Research Projects

Research Products

Co-Researchers

Impact of vessel co-option on systemic chemotherapy for hepatocellular carcinomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Exploration of target molecule for immunotherapy focusing on natural immuno-system of circulating tumor cellPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Surgical Intervention After Lenvatinib Treatment in Patients With Advanced Hepatocellular Carcinoma2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] A patient who underwent conversion surgery after atezolizumab plus bevacizumab for hepatocellular carcinoma with portal vein thrombosis and perihepatic lymph node metastases achieved a pathological complete response2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Sinusoidal Obstruction Syndrome Promotes Liver Metastatic Seeding of Colorectal Cancer Cells in a Rat Model. Anticancer Res. 2021;41(4):1803-1810. doi: 10.21873/anticanres.14946.2021

Author(s)

Journal Title

DOI

Data Source

[Presentation] Surgical intervention after lenvatinib treatment in patients with advanced hepatocellular carcinoma2023

Author(s)

Organizer

Data Source

Okuno Masayuki 奥野将之